Search research articles
Contact Us
Filters
Showing results (291-300 of 307) with videos related to
Page
of 31
Sort By:
Transplantation and Cellular Therapy
|
April 22, 2023
Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care
Benjamin Tomlinson, Marcos de Lima, Christopher R Cogle, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 4, 2020
Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology
Aaron T Gerds, Jason Gotlib, Prithviraj Bose, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 20, 2022
Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium
Polina Pyatilova, Cem Akin, Iván Alvarez-Twose, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 27, 2022
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium
Peter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 20, 2022
Proposed European Competence Network on Mastocytosis-American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis
Jason Gotlib, Juliana Schwaab, William Shomali, et al.
Journal of the American Academy of Dermatology
|
February 14, 2026
Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER study
Frank Siebenhaar, Sigurd Broesby-Olsen, Mariana Castells, et al.
JCO Precision Oncology
|
January 23, 2023
Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group
Miguel D Cantu, Rashmi Kanagal-Shamanna, Sa A Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 8, 2022
Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Aaron T Gerds, Jason Gotlib, Haris Ali, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 11, 2024
NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024
Jason Gotlib, Aaron T Gerds, Peter Abdelmessieh, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 24, 2021
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
Theo Gülen, Cem Akin, Patrizia Bonadonna, et al.
Page
of 31
Search research articles
Search
Showing results (291-300 of 307) with videos related to
Sort By:
Page
of 31
Transplantation and Cellular Therapy
|
April 22, 2023
Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care
Benjamin Tomlinson, Marcos de Lima, Christopher R Cogle, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 4, 2020
Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology
Aaron T Gerds, Jason Gotlib, Prithviraj Bose, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 20, 2022
Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium
Polina Pyatilova, Cem Akin, Iván Alvarez-Twose, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 27, 2022
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium
Peter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 20, 2022
Proposed European Competence Network on Mastocytosis-American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis
Jason Gotlib, Juliana Schwaab, William Shomali, et al.
Journal of the American Academy of Dermatology
|
February 14, 2026
Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER study
Frank Siebenhaar, Sigurd Broesby-Olsen, Mariana Castells, et al.
JCO Precision Oncology
|
January 23, 2023
Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group
Miguel D Cantu, Rashmi Kanagal-Shamanna, Sa A Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 8, 2022
Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Aaron T Gerds, Jason Gotlib, Haris Ali, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 11, 2024
NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024
Jason Gotlib, Aaron T Gerds, Peter Abdelmessieh, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 24, 2021
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
Theo Gülen, Cem Akin, Patrizia Bonadonna, et al.
Page
of 31